CA 19-9 Pancreatic Cancer Test | Lahalak Platform
Vital analysis for monitoring pancreatic and bile duct health, helping track tumor response to treatment and early detection of any health developments for rapid intervention.
Scientific name: Cancer Antigen 19-9 (CA 19-9) Test
The cancer antigen 19-9 (CA 19-9) serum test measures the level of a Lewis antigen-associated glycoprotein known as MUC1. This protein is produced by cells in the pancreatic and bile ducts. Its levels are significantly elevated in pancreatic (adenocarcinoma) cancer, cholangiocarcinoma, and some other gastrointestinal cancers. It can also be elevate...
Service type
Laboratory test (Blood)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Accurate analysis to diagnose the level of cancer antigen 19-9 (CA 19-9) in serum.
- Consult an oncologist or gastroenterologist/hepatologist to interpret the results.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- • The inspection does not require a maximum.
- It is important to inform the doctor about any conditions that may cause blockage in the bile ducts (stones, inflammation) or liver diseases, as these significantly raise the level and lead to false positive results.
- It is not used as a general screening test due to its low quality.
- For follow-up, it is preferable to use the same laboratory to ensure consistency of results.
Medical services you might also like
